The researchers collected roots, stems and flowers from the Cholistan Desert in Pakistan during June, a period associated in earlier work with high concentrations of phenolics, flavonoids and tannins in this species. Separate portions of each plant part were shade-dried for approximately 25 days, ground and extracted with absolute ethanol for seven days, with sonication used to enhance extraction. Liquid–liquid partition separated the crude material into n-hexane, dichloromethane and ethyl acetate fractions of differing polarity. The ethanolic stem extract was additionally separated by vacuum liquid chromatography into 13 fractions. This staged strategy was intended to connect particular chemical constituents with measured biological effects rather than treating the whole plant as an undifferentiated mixture.

In the anticancer arm of the study, the plant fractions were tested in HepG2 human liver-cancer cells and VERO cells, which served as a normal-cell comparator. An MTT assay measured metabolic cell viability, while phase-contrast microscopy examined changes in cell shape, density and organization. The ethyl acetate root fraction produced the strongest result among the tested root preparations, with 46% HepG2 cell viability and an IC₅₀ of 96.3 micrograms per millilitre. The other root fractions had similar half-maximal cytotoxic concentrations: 97 micrograms per millilitre for both dichloromethane and ethanol, and 98.78 micrograms per millilitre for n-hexane. Morphological observations included cell shrinkage, clumping, altered cell shape and disruption of the monolayer. By contrast, the tested extracts produced negligible cytotoxicity in the VERO cells under the reported conditions.

Stem fractions showed broadly similar activity, with approximately half of HepG2 cell viability remaining in the n-hexane, dichloromethane and ethyl acetate preparations. The crude ethanolic stem extract was less potent, leaving 55% viability and giving an IC₅₀ of 105.77 micrograms per millilitre. Flower fractions were less active against the cancer cells, with IC₅₀ values ranging from 122.88 to 181.26 micrograms per millilitre. These comparisons concern crude mixtures and in-vitro viability; they do not identify a single anticancer agent or demonstrate selective killing of liver-cancer cells in an animal or human setting. The researchers selected the ethyl acetate root fraction for chemical and computational examination because it had the lowest reported IC₅₀ among the root fractions and was supported by morphological changes.

LC-MS analysis tentatively identified a wide range of metabolites in the selected root fraction, including phenolic acids, flavan-3-ols, flavonol glycosides, triterpenoids, sterols and lignans. Prominent signals included catechin, epicatechin, galloylated quercetin derivatives, kaempferol glycosides, ursolic acid derivatives and alpha-viniferin. The presence of multiple glycosylated, galloylated and oligomeric forms indicated considerable structural diversity. Docking against the crystal structure of cyclin-dependent kinase 1 produced its most favourable predicted score for an ursolic-acid derivative, at −10.3 kcal/mol, followed by a prenylated isoflavanone and a complex glycoside at −9.0 and −8.7 kcal/mol. Catechin, epicatechin, quercetin galloylglucoside and isorhamnetin were also predicted to bind between −8.0 and −8.2 kcal/mol. These scores are computational estimates of pose and affinity, not measurements of enzyme inhibition, cellular penetration, selectivity or anticancer efficacy.

For the diabetes-related work, the ethanolic stem extract was the strongest crude preparation in the enzyme assays. Its IC₅₀ was 102.05 ± 0.65 micrograms per millilitre against alpha-amylase and 65.005 ± 1.555 micrograms per millilitre against alpha-glucosidase. Acarbose, the reference inhibitor, had an alpha-glucosidase IC₅₀ of 57.38 ± 0.95 micrograms per millilitre. The plant extract therefore approached the reference compound’s measured potency in this particular in-vitro test, although a lower IC₅₀ indicates greater inhibition. Non-polar stem and root fractions were less effective against alpha-amylase, with IC₅₀ values exceeding 600 micrograms per millilitre. Among the 13 chromatography fractions, V9 was the strongest alpha-glucosidase inhibitor, with an IC₅₀ of 47.97 micrograms per millilitre, while V13 was the strongest alpha-amylase inhibitor, with an IC₅₀ of 112.5 ± 0.6 micrograms per millilitre.

LC-MS profiling of V9 and V13 again revealed complex mixtures dominated by flavonoids, phenolic acids and glycosides. V9, obtained with 10% methanol in ethyl acetate, included 24 tentative assignments, among them procyanidin gallate, an epicatechin–epicatechin–catechin trimer, apigenin C-glycosides and a highly glycosylated isorhamnetin derivative. Docking against alpha-glucosidase ranked a quercetin–rhamnoside conjugate most favourably at −12.7 kcal/mol, followed by the epicatechin trimer at −12.5 and procyanidin B2 3′-O-gallate at −12.4 kcal/mol. For alpha-amylase, the V13 predictions were less extreme: a prenylated flavonoid scored −9.8 kcal/mol, while two tricin diglucuronoside entries and a diprenylisoflavanone scored −9.5 to −9.4 kcal/mol. Smaller acids, including isovaleric acid and 2-hydroxyisobutyrate, had much weaker scores of −4.1 and −4.3 kcal/mol. The calculations suggest that hydroxyl groups, sugar residues, aromatic systems and molecular bulk may favour predicted enzyme binding, but they cannot establish which compounds caused the experimental inhibition.

The study also evaluated the crude stem extract and the V9 and V13 fractions in an alloxan-induced diabetes experiment in male Wistar rats weighing 230–260 grams. After a single 120 mg/kg intraperitoneal dose of alloxan, diabetes was confirmed three days later by fasting blood glucose. Animals were assigned to untreated, diabetic-control, glibenclamide, crude-stem-extract, V9 and V13 groups, with four rats per group, and treatments were administered orally for seven days. The diabetic-control group remained near 239 milligrams per decilitre on day 7, while the glibenclamide group declined from 226 to 108.6 milligrams per decilitre. The crude stem extract fell from 243.6 to 141, V9 from 241.6 to 167 and V13 from 216 to 145.6 milligrams per decilitre. All treated diabetic groups differed significantly from the diabetic control on days 3, 5 and 7, according to the reported analysis with p < 0.001. The plant treatments produced smaller final reductions than glibenclamide, and the small groups, short duration and absence of reported dose details limit interpretation.

Computational pharmacokinetic analysis highlighted a major obstacle between promising fractions and a practical medicine. Smaller compounds such as 4-vinylphenol, isovaleric acid, kaempferide and several modest-sized flavonoids were predicted to have high gastrointestinal absorption. In contrast, many large glycosylated flavonoids and oligomeric polyphenols had low predicted absorption, low blood–brain-barrier permeability and, in several cases, possible P-glycoprotein substrate status. Large triterpenoids and stigmasterol were predicted to have poor oral absorption because of high lipophilicity. These are structure-based predictions rather than measurements of blood concentrations, metabolism, excretion or toxicity. Together, the findings support further investigation of selected constituents and bioassay-guided fractions, but not clinical use. The strongest supported conclusion is that C. polygonoides contains chemically diverse materials with measurable cytotoxic, enzyme-inhibitory and glucose-lowering activity in laboratory and rodent models; their safety, effective doses, mechanisms and human relevance remain unestablished.

Subject of Research: Preclinical anticancer and antidiabetic evaluation of Calligonum polygonoides extracts and fractions

Article Title: Phytochemical profiling, LC-MS characterization, anticancer and antidiabetic evaluation of calligonum polygonoides; in vitro , in vivo and in silico insights

Article References: Sadiq, F., Shahzad, M. I., Anjum, S., Rashid, S., Abass, K. S., Eman, K., Tahir, T., Hadi, F., & Rivera, G. (2026). Phytochemical profiling, LC-MS characterization, anticancer and antidiabetic evaluation of calligonum polygonoides; in vitro, in vivo and in silico insights. Results in Chemistry, 31, Article 103987. https://doi.org/10.1016/j.rechem.2026.103987

Image Credits: AI Generated

DOI: 10.1016/j.rechem.2026.103987

Keywords: Calligonum polygonoides, desert medicinal plants, LC-MS, HepG2 cells, alpha-glucosidase inhibition, alpha-amylase inhibition, alloxan-induced diabetes, molecular docking, pharmacokinetics, polyphenols, Phytochemical, profiling

The study, published in the journal NeoBiota, examined honey, hive-stored pollen and honeycomb from two apiaries positioned near widespread ragwort populations in Prague. The plant, which reaches 30 to 100 centimetres in height and flowers from June to November in Central Europe, arrived in Europe in the late nineteenth and early twentieth centuries through wool-processing facilities. Since then it has colonised warm, sandy and gravelly disturbed soils along transport corridors across the continent, and climate change with mild winters and warm, dry growing seasons may facilitate its further spread. The concern driving the research is that the species contains nine pyrrolizidine alkaloids, including integerrimine, retrorsine, senecionine, seneciphylline, senecivernine and usaramine, with the highest concentrations found in young shoots and inflorescences.

Pyrrolizidine alkaloids themselves are not directly toxic to vertebrates. The danger emerges after ingestion, when the liver metabolises them into reactive pyrrole derivatives that bind to DNA and proteins, causing liver cell death, progressive cirrhosis and eventually liver failure. Some of the compounds are mutagenic and genotoxic, and significant effects on the metamorphosis of Hymenoptera have also been demonstrated. The toxins enter the human food chain most often through contamination of agricultural products by weeds, or through food supplements and traditional medicinal products such as certain teas. Honey is a well-documented route, with quantities sometimes reaching tens to hundreds or even thousands of micrograms per kilogram. According to the German Federal Institute for Risk Assessment, daily doses should not exceed 0.007 micrograms per kilogram of body weight, a threshold that underscores how little contamination is needed to raise concern.

The research team collected five honey samples spanning the entire growing season, along with one sample of hive-stored pollen and one honeycomb sample, from hives at two Prague localities where ragwort is widespread. A reference sample of ragwort inflorescences was also gathered to establish the pollen grain profile of the species. All samples underwent pollen analysis in December 2019 using a standard acetylation method, chosen for its robustness against contamination by non-pollen particles, whereas newer approaches such as metabarcoding could produce false positives and noise. Because ragwort pollen grains are not morphologically distinct from those of other Senecio species or similar members of the daisy family, the researchers classified them under a general Aster/Senecio pollen type.

The pollen analysis revealed a strikingly low presence of the Aster/Senecio type across all seven samples. The pollen type appeared only in one sample, the hive-stored pollen from hive 1 collected in August 2019, and even there in small quantities. Based on the pollen spectrum, the researchers concluded that bees preferred honeydew from flowering woody plants as their main food source, largely bypassing the ragwort stands despite their proximity. The honey samples themselves contained only low concentrations of pollen grains, with crystallised sugar visible, further indicating that the bees were not heavily exploiting the invasive herb.

Chemical analysis provided the second line of evidence. Using liquid chromatography coupled with mass spectrometry in January 2020, the team screened for 29 different pyrrolizidine alkaloids or their N-oxides across four honey samples. The analysis detected no such alkaloids originating from ragwort. The only compound found above the limit of detection was echimidin, a pyrrolizidine alkaloid traced in three honey samples at low concentrations ranging between 1 and 7 micrograms per kilogram. The likely source was not the invasive ragwort at all, but Echium vulgare, the common viper’s bugloss, a plant known as one of the major causes of pyrrolizidine alkaloid contamination in honey and found to be abundant in the vicinity of the studied sites. Pollen analysis of one honey sample also revealed the presence of Echium pollen type, corroborating the chemical finding. Nectar, the researchers noted, appears to be a more significant source of the alkaloids in honey than pollen in the case of viper’s bugloss.

The results align with the only comparable study available, research on S. jacobaea, which found minimal Senecio-type pollen in honey at 0 to 6.3 percent, consistent with the Prague findings. The low contamination likely reflects the current flowering phenology of narrow-leaved ragwort. Over the past twenty years the species has begun to bloom in June or July, a period when bees have abundant alternative forage. The researchers caution, however, that this timing is shifting. In recent years ragwort has already been observed blooming in May, and in warmer parts of Central Europe still-flowering overwintering stems have been recorded as early as February. Should the species start flowering earlier in the season, the risk of contamination would increase significantly, because in early spring other sources of honeydew and pollen are scarce and bees may turn to ragwort as an alternative resource.

Autumn flowering, by contrast, may not pose as significant a risk, since many beekeepers leave the honey from the last flow with the bees to help them overwinter, keeping it out of circulation. The geometry of foraging also matters. Bees typically use resources from up to about 3 kilometres from the hive, but if forage is dense enough they usually travel shorter distances. This behaviour suggests that hives for studying alkaloid content in honey and pollen should be placed in the immediate vicinity of the studied plant population, so that the species is offered to the bees as the most easily accessible forage. The Prague hives satisfied this condition, strengthening the conclusion that ragwort currently contributes minimally to honey contamination.

The pilot study’s overall verdict is that honey from hives near large ragwort populations contained negligible pollen and no ragwort-derived pyrrolizidine alkaloids, posing no health risk to consumers under current conditions. The researchers emphasise that the current flowering phenology of the invasive species minimises its potential negative impact on human health, but they stress that phenology is slowly changing. As the plant blooms earlier in the year, the alkaloids and pollen in honey need to be monitored to assess future risks, making continued surveillance of this alien invader an essential part of protecting both beekeeping and public health.

Subject of Research: Pilot study on pyrrolizidine alkaloid contamination in honey from hives near invasive Senecio inaequidens populations in Prague

Article Title: Toxin-free honey despite the alien Senecio inaequidens DC. invasion – a pilot study

Article References: Karlík, P., Kutlvašr, J., Kušková, K., Petr, L., Vachová, P., & Pergl, J. (2026). Toxin-free honey despite the alien Senecio inaequidens DC. invasion – a pilot study. NeoBiota, 106, 357-367. https://doi.org/10.3897/neobiota.106.175238

Image Credits: AI Generated

DOI: 10.3897/neobiota.106.175238

Keywords: Senecio inaequidens, invasive species, pyrrolizidine alkaloids, honey safety, beekeeping, pollen analysis, LC-MS, NeoBiota, Prague, Echium vulgare, food safety, flowering phenology

The review, led by Xiaoyue Shan and colleagues at Hangzhou Occupational Disease Prevention and Treatment Hospital in China, critically examined liquid chromatographic and electrochemical methods published between 2018 and 2024. The stakes could not be higher. Morphine produces physical and psychological dependence, and overdoses can trigger respiratory failure, nausea, vomiting, central nervous system disorders and even death. Monitoring morphine and its transformation products in biological specimens is therefore essential for overseeing drug addicts, tracking drug abuse and supporting clinical pain management decisions.

What makes morphine analytically interesting is its metabolism. Approximately 90 percent of orally administered morphine is eliminated via urine within 24 hours, with nearly 10 percent remaining in its unmetabolized form. The majority is absorbed by the liver through the organic cation transporter and undergoes rapid metabolism predominantly mediated by the enzyme UGT2B7, generating two glucuronide metabolites with dramatically different biological activities. Morphine 6-glucuronide, or M6G, possesses potent analgesic properties and has been shown in clinical research to contribute to the effects produced by morphine itself, with antinociceptive potency roughly 50 times greater than the parent compound. In contrast, morphine 3-glucuronide, or M3G, has no analgesic potency but may exert anti-analgesic and neuroexcitatory effects. Distinguishing between these metabolites is not merely an academic exercise; it directly affects how clinicians interpret drug concentrations in patients.

Before any detection can happen, however, the biological matrix itself must be tamed. Endogenous compounds such as organic matter, fats, proteins and other interferents significantly affect the reproducibility, sensitivity and selectivity of measurements. The review details the full spectrum of sample pretreatment strategies. Simple dilution and centrifugation can minimize matrix effects, as demonstrated in one LC-MS/MS protocol that analyzed 17 abused substances in oral fluid by diluting 40 microliters of sample with 160 microliters of water before centrifugation. More commonly, liquid-liquid extraction and solid-phase extraction are the most frequently practiced approaches. Liquid-liquid extraction offers simplicity and high extraction coefficients but consumes large quantities of sample and organic solvents, with methanol, chloroform, acetonitrile and various solvent mixtures employed depending on the target analytes.

Solid-phase extraction has become the workhorse for preconcentrating morphine and its metabolites, and the choice of adsorbent greatly affects analytical performance. The review catalogs an impressive array of materials, including polyoxometalate-based frameworks, carbon nanotubes, graphene oxide and molecularly imprinted polymers. One particularly promising development is magnetic solid phase extraction, which uses environmentally friendly magnetic adsorbents. In one study, a graphene oxide-Fe3O4 nanocomposite was synthesized for simultaneous preconcentration of eight psychoactive drugs, including morphine, from urine samples prior to UHPLC-MS/MS analysis, achieving recoveries ranging from 80.4 to 105.5 percent. The magnetic approach demonstrated lower costs, easier handling and better reusability compared with conventional pretreatment methods, showing significant potential for monitoring psychoactive drugs in clinical and forensic settings.

On the chromatographic side, high-performance liquid chromatography coupled with ultraviolet or photodiode array detection remains widely used due to its easy operation and relatively low cost. One HPLC-UV method using a Fe3O4/reduced graphene oxide/silver nanocomposite for magnetic solid phase extraction achieved a limit of detection of 1.8 nanograms per liter for morphine with an enrichment factor of 1000 and relative recoveries between 97.0 and 102.5 percent in human samples. However, the review notes that some UV-based methods exhibit limited sensitivity, with the lowest limit of detection obtained using UV detection being 0.1 nanograms per milliliter. The real revolution came with mass spectrometry. LC-MS/MS methods employing electrospray ionization in positive mode, typically with triple quadrupole mass analyzers and multiple reaction monitoring, offer superior sensitivity and specificity. One validated SPE-LC-MS/MS method for plasma achieved limits of detection between 0.05 and 0.2 nanograms per milliliter for morphine and its glucuronide metabolites, with negligible matrix effects and successful validation through clinical plasma sample analysis.

Ultra-high-performance liquid chromatography has pushed these boundaries even further. UHPLC-MS/MS offers improved resolution, higher precision and dramatically reduced analysis times. One method for postmortem blood achieved a morphine retention time of just 1.24 minutes with a limit of detection of 1.23 nanograms per milliliter, analyzing 84 drugs across more than 12 classes. Another approach using dried blood spots required only 0.83 minutes of separation and was applied to 64 real samples. Perhaps most remarkably, a UHPLC-ESI-MS/MS method using TpBD-COF-functionalized magnetic nanospheres achieved limits of detection as low as 0.53 picograms per milliliter for morphine, 0.33 picograms per milliliter for M3G and 0.16 picograms per milliliter for M6G in mouse urine. These methods have been applied to over 11,000 antemortem and postmortem blood samples, demonstrating robustness at forensic scale.

Yet the review reserves its most enthusiastic attention for electrochemical sensors, which it highlights as a primary analytical approach. These devices offer high sensitivity, low cost, portability and the ability to analyze complex samples with minimal pretreatment. The technical foundation lies in modified electrodes coated with functional nanomaterials that enhance signal transduction. Carbon nanotube-based electrodes have proven particularly versatile. One MgO-decorated single-walled carbon nanotube sensor achieved a limit of detection of 0.8 nanomolar across a linear range spanning 0.003 to 320 micromolar. A Nafion/SWCNT sensor strip demonstrated direct electrochemical determination in untreated capillary whole blood with a total assay time of only several minutes and a sample volume of 40 microliters, showing real potential for point-of-care morphine testing. Graphene-based electrodes have pushed sensitivity further, with one graphene/Co3O4 composite achieving a limit of detection of 80 nanomolar and a peak current 12.5 times higher than a bare electrode.

Metal and metal oxide-based electrodes have delivered equally impressive results. A rhodium nanoparticle-decorated mesoporous carbon sensor achieved a limit of detection of 40 nanomolar for morphine and 45 nanomolar for buprenorphine. An ultrasensitive Au-Ag nanoparticle-modified ZIF-67 sensor on a screen-printed carbon electrode reached a limit of detection of just 3 nanomolar across a broad linear range of 0.05 to 600 micromolar. Polymer-based sensors have added molecular recognition capabilities, with one molecularly imprinted polymer sensor using L-lysine functionalized sodium alginate-activated carbon demonstrating that a 10-fold excess of codeine, heroin, naltrexone and buprenorphine caused no significant interference, achieving a limit of detection of 48 nanomolar in real human urine samples.

The comparison between chromatographic and electrochemical methods reveals a fundamental trade-off. Mass spectrometry offers high accuracy but is frequently time-consuming, costly and large, making it inaccessible to many clinical laboratories. Electrochemical sensors offer rapid response, cost-effectiveness and portability, but matrix effects in real samples can significantly affect sensitivity and recovery, and these issues have prevented the commercial development of many sensors, limiting their use to academic research. Most critically, the review identifies a significant gap: no electrochemical methods have yet been reported that can distinguish morphine from its major metabolites M3G and M6G, which remains a substantial challenge given their overlapping electrochemical behavior. The authors conclude that future studies should focus on enhancing the sensitivity and selectivity of both electrochemical and mass spectrometric methods, miniaturizing these systems for portable on-site analysis, and improving cost-effectiveness to facilitate large-scale application. As the opioid crisis continues to demand faster, cheaper and more accessible testing, the race between the laboratory gold standard and the point-of-care challenger is only just beginning.

Subject of Research: Analytical Chemistry

Article Title: Current methodologies to the analysis of morphine and its metabolites in biological matrices

Article References: Shan, X., Yang, B., Zhang, L., Shao, J., Jin, Y., Qiu, J., Tan, S., Ye, H., & Le, Y. (2026). Current methodologies to the analysis of morphine and its metabolites in biological matrices. Frontiers in Analytical Science, 5, Article 1680414. https://doi.org/10.3389/frans.2025.1680414

Image Credits: AI Generated

DOI: 10.3389/frans.2025.1680414

Keywords: morphine, LC-MS, electrochemical sensors, UHPLC-MS/MS, opioid detection, biological matrices, sample preparation, point-of-care testing, analytical chemistry, forensic toxicology, Current, methodologies

The experimental system involved only three inexpensive and widely available components under atmospheric pressure. Dextrose monohydrate (3.500 g, 19.43 mmol) and sodium bicarbonate (2.500 g, 29.76 mmol) were dissolved in 100.0 mL of deionized water under continuous magnetic stirring until complete dissolution was achieved. The resulting homogeneous solution was heated to 100 °C and maintained at this temperature for 5 minutes under atmospheric pressure. During thermal treatment, gas evolution was observed throughout the reaction medium. This observation is consistent with the expected behavior of the bicarbonate/carbonate/CO2 equilibrium under aqueous heating; however, the authors stress that gas evolution was not considered direct evidence of carbohydrate transformation, because carbon dioxide release may arise from bicarbonate speciation or thermal decomposition independently of glucose modification. Following cooling to room temperature, solvent removal was performed by lyophilization, yielding the recovered dry carbohydrate-containing material designated glucosodiene.

The recovered material was evaluated by 13C NMR, 1H NMR, FTIR, and LC-MS. Among the analytical techniques employed, 13C NMR provided important evidence for structural diversification within the recovered material. Multiple resonances were observed within the anomeric carbon region between approximately 92 and 104 ppm, together with numerous oxygenated carbon signals distributed throughout the 67–83 ppm region. Additional resonances near 61–64 ppm remained consistent with CH2OH-containing carbohydrate environments. The coexistence of several anomeric carbon environments is consistent with the presence of multiple carbohydrate-associated chemical states rather than a single homogeneous glucose population. Importantly, the spectrum retained characteristic oxygen-rich carbohydrate signals while exhibiting diversification within the anomeric and oxygenated carbon regions, supporting preservation of carbohydrate-derived structural features alongside the emergence of additional chemical environments during the aqueous dextrose–bicarbonate treatment.

Complementary information was obtained from 1H NMR spectroscopy. Signals within the characteristic carbohydrate region, approximately 3.0–4.5 ppm, were consistent with protons attached to oxygenated carbon centers, while resonances near 4.8–5.0 ppm corresponded to anomeric proton environments. Collectively, the 1H NMR data support retention of substantial carbohydrate character while indicating the presence of multiple chemically distinct proton environments. When considered together with the 13C NMR findings, these results are consistent with the formation of a structurally diversified carbohydrate-derived material rather than simple recovery of a single unchanged glucose species.

Further evidence was obtained from FTIR spectroscopy, which indicated that the recovered material remained highly oxygenated. A broad hydroxyl stretching band centered near 3,411 cm−1 was observed together with strong absorptions throughout the carbohydrate fingerprint region. Particularly prominent were bands associated with C–O and C–O–C stretching vibrations, consistent with oxygen-rich carbohydrate-derived functionality. The persistence of intense hydroxyl absorption suggests retention of hydrogen-bonding capability, a feature that may contribute to supramolecular association within the recovered material. However, FTIR does not define molecular connectivity and cannot by itself exclude residual inorganic species, unreacted carbohydrate, or minor degradation products. Therefore, the FTIR data are interpreted as supporting preservation of carbohydrate-associated functionality rather than proving a fully defined structure.

Additional support for chemical diversification was provided by LC-MS analysis. The chromatographic profile revealed two closely associated dominant peaks at retention times of approximately 0.70 and 0.77 minutes. The corresponding mass spectra displayed recurring ions across both chromatographic features, including signals centered around m/z 178.9, 22.9, 316.8, 384.9, 452.9, 520.9, 588.9, and several higher-mass species. The recurrence of these ions across multiple chromatographic features is compatible with the existence of a heterogeneous population of structurally related carbohydrate-derived species generated within the reaction environment. Although these observations do not establish precise molecular connectivity or the identities of individual compounds, they are not adequately explained by a single unmodified glucose species and instead support the presence of a chemically diversified carbohydrate-containing material system.

Individually, none of the analytical techniques employed establishes the complete molecular architecture of glucosodiene. However, when interpreted collectively, the available data indicate that the recovered material is not adequately described as a single homogeneous native dextrose preparation and that it preserves substantial carbohydrate character while exhibiting additional anomeric, oxygenated, and mass-spectrometric features. This finding is consistent with the central premise of the present interpretation: namely, that mild bicarbonate-associated aqueous heating may be associated with carbohydrate-derived structural diversification without complete destruction of the underlying carbohydrate scaffold. At the same time, the present evidence should be interpreted within clear analytical limitations. The current dataset does not yet quantify the extent of glucose conversion, define the identities of the individual products, measure residual bicarbonate/carbonate content, or establish molecular-weight distribution. Consequently, glucosodiene should presently be regarded as an operationally designated carbohydrate-derived material system rather than a single fully resolved molecular entity.

The significance of glucosodiene should be interpreted cautiously. The present data do not establish glucosodiene as a single fully defined molecular entity, nor do they prove a selective bicarbonate-controlled pathway. Rather, the observations provide preliminary evidence that a simple dextrose–bicarbonate aqueous treatment can yield a recovered carbohydrate-derived material system that differs analytically from native dextrose while retaining substantial carbohydrate character. A notable feature emerging from the analytical data is the preservation of oxygen-rich carbohydrate-associated signatures despite the appearance of multiple chemically distinct environments. The combined NMR, FTIR, and LC-MS observations indicate that the recovered material retains hydroxyl functionality, carbohydrate-associated proton and carbon environments, and recurring mass features while exhibiting chemical heterogeneity beyond a single homogeneous glucose population. Such a combination is relevant from a biomaterials perspective because hydrated oxygen-rich architectures may contribute to aqueous compatibility, intermolecular recognition, polymer interaction, and biological interfacing. Mechanistically, this behavior may arise from the interplay of several dynamic processes operating simultaneously within the reaction environment, including glucose mutarotation, transient enediol formation, bicarbonate-associated proton-transfer events, thermal activation, and reorganization of hydrogen-bonding networks. Rather than producing a single discrete molecular entity, these processes may generate a chemically heterogeneous material system characterized by multiple related structural states, conceptually consistent with principles of systems chemistry and self-organization, where functional complexity may emerge from dynamic interactions among relatively simple molecular building blocks.

The translational relevance of glucosodiene is suggested, but not proven, by its reported incorporation into ferrite–chitosan nanostructured systems exhibiting biological activity in vivo. These findings indicate that glucosodiene-containing formulations can be integrated into advanced nanostructured platforms; however, they do not yet define the independent contribution of glucosodiene, the role of the ferrite–chitosan matrix, or the precise biological mechanisms involved. Therefore, these studies should be interpreted as supportive proof-of-application for further biomaterials investigation rather than definitive evidence that glucosodiene possesses intrinsic therapeutic activity. The oxygen-rich character of glucosodiene may facilitate interaction with polymeric matrices, metal-oxide nanoparticles, therapeutic cargos, and biological interfaces through hydrogen bonding, hydration effects, and multivalent intermolecular interactions, but these proposed interactions require direct experimental validation.

An important issue is the relationship between the present interpretation and established glucose isomerization, dehydration, and degradation chemistry. Glucose is known to undergo mutarotation, base- or acid-associated isomerization, enediol-mediated rearrangement, dehydration, fragmentation, and condensation under suitable conditions. Therefore, the novelty of the present work should not be understood as the discovery that glucose can be chemically transformed. Instead, the proposed contribution is the observation that a short, simple, bicarbonate-containing aqueous treatment produces a recovered carbohydrate-derived material system that preserves substantial oxygen-rich carbohydrate character while displaying additional anomeric, oxygenated, and mass-spectrometric features. The possibility of glucose-derived humin or humin-like by-product formation must also be considered. Humins are generally described as chemically heterogeneous, carbonaceous, polymeric by-products formed during acid-catalyzed or dehydration-driven conversion of biomass-derived sugars. In contrast, the present material was obtained after a short aqueous treatment under bicarbonate-associated conditions and retained strong carbohydrate-associated NMR and FTIR signatures, including multiple oxygenated carbon environments, anomeric signals, hydroxyl absorption, and C–O/C–O–C features. These observations suggest that the recovered material should not be automatically assigned as a classical acid-derived glucose humin. However, the current dataset does not exclude the presence of humin-like minor products, dehydration products, unreacted glucose, or bicarbonate-associated inorganic residues. Distinguishing glucosodiene from unreacted carbohydrate, inorganic salts, dehydration products, and humin-like by-products requires further controlled characterization.

A further unresolved point concerns the specificity of bicarbonate. Gas evolution observed during heating cannot by itself be used as evidence of carbohydrate reorganization, because CO2 release may arise from bicarbonate/carbonate/CO2 speciation or thermal decomposition independently of glucose transformation. Accordingly, the role of bicarbonate should be considered provisional until appropriate controls are performed. Future studies should compare glucose-only, bicarbonate-only, glucose plus bicarbonate, pH-matched alkaline controls, carbonate controls, and ionic-strength controls under identical time-temperature conditions. Such comparisons will be essential for determining whether bicarbonate contributes specifically to carbohydrate diversification or primarily acts as a mild alkaline medium. Another implication concerns the possible position of glucosodiene within the continuum between small carbohydrate molecules and higher-order carbohydrate assemblies. The coexistence of multiple anomeric environments, recurring oxygen-rich motifs, and heterogeneous mass distributions is compatible with supramolecular association, low-molecular-weight oligomeric populations, or proto-polymeric behavior. However, the current evidence does not justify classification of glucosodiene as a classical polymer or as a structurally defined oligomer. Molecular-weight-distribution studies, SEC/GPC, DOSY NMR, MALDI-TOF, and high-resolution tandem mass spectrometry will be required to clarify whether the recovered material contains oligomeric, supramolecular, or salt-associated carbohydrate populations.

A related unanswered question concerns the possible relationship between glucosodiene and biological recognition processes. Because glucosodiene originates from glucose while retaining substantial carbohydrate-associated features, reorganized carbohydrate architectures may interact with biological systems in ways that differ from both native glucose and conventional polysaccharides. Future investigations should therefore evaluate cellular recognition, membrane interaction, transport behavior, metabolic processing, lectin binding, and potential interactions with glucose-associated biological pathways. If such interactions are confirmed experimentally, glucosodiene-like systems may represent metabolically relevant carbohydrate-derived biomaterials capable of functions beyond conventional carrier or structural roles. At present, however, this remains a hypothesis rather than an established biological mechanism. Several important limitations must therefore be acknowledged. The available analytical evidence does not permit definitive assignment of linkage positions, stereochemical configurations, molecular connectivity patterns, individual product identities, conversion extent, residual bicarbonate/carbonate content, or degree of oligomerization. Consequently, glucosodiene should currently be regarded as a structurally diversified carbohydrate-derived material system rather than a fully resolved molecular entity. Comprehensive structural characterization using quantitative HPLC or UPLC, qNMR with internal standards, HSQC, HMBC, COSY, NOESY, DOSY NMR, HRMS/MS, MALDI-TOF analysis, SEC/GPC measurements, ion chromatography, conductivity analysis, elemental analysis, ash-content determination, TGA/DSC, and molecular-weight-distribution studies will be essential for defining the structural and compositional boundaries of this material system.

Future studies should also investigate how reaction time and temperature influence the composition of the recovered material. Excessive heating of glucose is known to promote dehydration, fragmentation, condensation, and humin-like product formation. Therefore, systematic time-course and temperature-course experiments will be required to determine whether the short bicarbonate-associated treatment described here occupies a distinct region between simple glucose recovery and extensive degradation. Such studies should include visual monitoring, solubility assessment, UV–visible analysis for browning or conjugated chromophores, comparison with glucose-derived humin references, and quantitative measurement of unreacted glucose and inorganic residues. Finally, future work should test whether bicarbonate-associated carbohydrate diversification can be generalized beyond glucose. Other monosaccharides, including fructose, galactose, mannose, ribose, and biologically relevant oligosaccharides, represent attractive candidates for evaluating the scope and limitations of the proposed interpretation. Demonstration of analogous behavior across multiple carbohydrate families, together with reproducible purification and quantitative characterization, would help determine whether this approach can be developed into a broader platform for generating carbohydrate-derived material systems.

Taken together, the current findings suggest that the importance of glucosodiene lies not solely in its unresolved chemical identity, but in its role as an initial experimental model for exploring bicarbonate-associated carbohydrate diversification. The central question emerging from this work is therefore not simply what glucosodiene is, but rather whether simple bicarbonate-containing aqueous environments can access carbohydrate-derived material states that are distinct from native glucose, classical selective glycosylation products, and extensively degraded humin-like materials. If future controlled and quantitative investigations answer this question affirmatively, glucosodiene-like systems may provide a useful conceptual bridge connecting carbohydrate chemistry, systems chemistry, supramolecular organization, biomaterials engineering, nanotechnology, and future healthcare applications. This Perspective presents glucosodiene as an operationally designated carbohydrate-derived material system obtained from a dextrose–sodium bicarbonate–water system under mild aqueous heating. The combined 13C NMR, 1H NMR, FTIR, and LC-MS observations indicate that the recovered material is not adequately described as a single homogeneous native dextrose preparation, while retaining oxygen-rich carbohydrate-associated features. However, the present evidence does not establish a selective bicarbonate-controlled mechanism, individual product identities, conversion extent, residual bicarbonate/carbonate content, molecular connectivity, or molecular-weight distribution. Therefore, glucosodiene should be considered a preliminary experimental model for bicarbonate-associated carbohydrate diversification. Further controlled, quantitative, and high-resolution studies are required to distinguish it from unreacted glucose, inorganic residues, degradation products, and humin-like materials and to assess its future relevance to carbohydrate-enabled nanomedicine platforms.

Subject of Research: Biomaterials Science

Article Title: Glucosodiene as a carbohydrate-derived material system: preliminary evidence from dextrose–bicarbonate aqueous diversification and potential relevance to future nanomedicine

Article References: Akl, M., & Ahmed, A. (2026). Glucosodiene as a carbohydrate-derived material system: preliminary evidence from dextrose–bicarbonate aqueous diversification and potential relevance to future nanomedicine. Frontiers in Biomaterials Science, 5, Article 1896271. https://doi.org/10.3389/fbiom.2026.1896271

Image Credits: AI Generated

DOI: 10.3389/fbiom.2026.1896271

Keywords: glucosodiene, carbohydrate-derived materials, bicarbonate-associated carbohydrate diversification, dextrose, nanomedicine, biomaterials, NMR spectroscopy, LC-MS, supramolecular chemistry, carbohydrate-derived, material, system

The research, published in the journal Advances in Drug and Alcohol Research, drew on a prospective sample of 2,872 acutely hospitalized internal medicine patients recruited at Lovisenberg Diaconal Hospital in Oslo between November 2016 and December 2017. During the original study, patients self-reported their drinking using the four-item Alcohol Use Disorder Identification Test, known as AUDIT-4, and provided blood samples analyzed with liquid chromatography-mass spectrometry, or LC-MS, to detect illicit drugs such as tetrahydrocannabinol, amphetamine, methamphetamine, cocaine, MDMA, and heroin. Crucially, none of this information was ever shared with the hospital staff treating those patients. That design choice transformed the study data into a gold-standard benchmark against which the physicians’ own documentation could be measured.

From the original cohort, the researchers identified 688 patients whose drinking exceeded low-risk guidelines, defined as AUDIT-4 scores of at least 5 for women and 7 for men, and/or who tested positive for one or more illicit drugs. Electronic records were available for 653 of them, comprising 548 alcohol-positive patients and 157 illicit drug-positive patients, with 48 individuals appearing in both groups. The team then combed through admission records and discharge summaries, scoring an alcohol assessment as complete only if it described both the quantity and frequency of consumption, for example units of alcohol per week, and a drug assessment as complete only if it named the substance and described how often it was used. Vague phrases such as “drinks moderately” or “recreational drug use” were classified as incomplete.

The findings were sobering. Among the 548 patients with study-verified drinking above low-risk thresholds, physicians documented quantity and frequency in only 43.2 percent of records, equivalent to 237 patients. An alcohol-related intervention, whether counseling, planned follow-up with a family physician, or referral to a treatment institution, was recorded in just 22.0 percent, or 121 patients. Perhaps most telling, only 9.1 percent of alcohol-positive patients received an alcohol-related ICD-10 diagnosis code at discharge, and even among those with scores indicating harmful drinking or possible dependence, coding rose to just 20.7 percent. For illicit drug users, the picture was similar: a complete assessment appeared in 34.4 percent of records and an intervention in 26.0 percent.

The timing of documentation mattered as much as its presence. In admission records of alcohol-positive patients, 41.8 percent contained complete quantity and frequency assessments and 15.2 percent contained no mention of alcohol at all. By discharge, the situation had deteriorated sharply: only 18.6 percent of discharge summaries included a complete assessment, and 56.9 percent made no reference to alcohol whatsoever. A parallel pattern emerged for drug-positive patients, with complete assessments falling from 31.2 percent at admission to 28.5 percent at discharge, while 44.6 percent of discharge records omitted illicit drug use entirely. Because discharge summaries are the primary channel of information to the general practitioners who manage post-hospital care, this attrition represents a systematic loss of clinically vital information at exactly the moment it matters most for continuity of treatment.

Statistical modeling revealed which patients were most likely to receive thorough attention. Complete quantity and frequency assessments of alcohol use were independently associated with harmful drinking levels, with each additional year of age, and were significantly less likely during outpatient emergency department evaluations compared with ward admissions. Interventions were strongly linked to harmful drinking, with an adjusted odds ratio of 4.87, and to the presence of a complete quantity and frequency assessment itself, which tripled the odds of an intervention at an adjusted odds ratio of 3.66. Psychological distress, measured by the Symptom Checklist-5, and unemployment also independently predicted intervention. The relationship between assessment and intervention is the study’s central mechanistic insight: physicians cannot counsel patients about drinking patterns they have never quantified, making documentation the gateway through which all subsequent preventive action must pass.

Why does this gap between verified substance use and recorded substance use persist? The authors point to the unforgiving tempo of emergency care, where time pressure and crowding squeeze the space available for detailed history taking, a hypothesis supported by the lower documentation rates among outpatients evaluated and discharged within hours. But the stakes of omission are high even at consumption levels well below overtly harmful thresholds. Recent population-level analyses have demonstrated a dose-response relationship between alcohol intake and all-cause mortality beginning around 100 grams per week, and at-risk drinking worsens outcomes across a remarkable range of common hospital conditions: it increases recurrence of atrial fibrillation, raises the risk of heart failure readmission, undermines glycemic control in diabetes, contributes to falls in older adults, reduces medication adherence, complicates anticoagulant therapy, and interacts dangerously with psychoactive prescriptions. Unrecognized heavy drinking also leaves patients vulnerable to withdrawal syndromes, whose most severe manifestation, delirium, can be fatal.

The study’s authors argue that the tools to close this gap already exist and are neither burdensome nor experimental. AUDIT-4 takes minutes to administer and can be simplified further to just the quantity and frequency questions, and patients in the study readily disclosed both at-risk and harmful drinking when asked. Brief interventions delivered in emergency departments have been shown to reduce at-risk drinking in the short term, and alcohol interventions in primary care produce measurable reductions in harmful drinking at twelve months. The most promising structural solution may be technological: embedding screening questions directly into electronic triage forms has achieved screening rates approaching 97 percent in prior research, whereas physician-directed training alone has yielded more modest results. The authors also suggest that clinicians could make fuller use of ICD-10 codes that denote alcohol use without implying harm, since more consistent coding would improve the registries used to estimate the true scale of alcohol-related harm in hospital populations.

Limitations remain, and the authors acknowledge them candidly. The data come from a single mid-sized urban hospital, so local documentation practices may not generalize everywhere; self-reported alcohol consumption is subject to recall bias, though typically in the direction of under-reporting, which would make the true prevalence of at-risk use even higher; and some counseling may have occurred without ever being written down. The illicit drug analyses were under-powered for regression modeling, and laboratory detection of a drug says nothing about dosage or frequency. Yet the core conclusion stands with unusual clarity. Hospital admission is one of the few moments when a person with risky drinking or drug use is guaranteed contact with the health system, and this study shows that in most cases that moment slips past unused. Treating substance use documentation with the same rigor as tobacco status, allergy lists, and medication records, and verifying that discharge summaries carry it forward, would convert a routine hospital stay from a missed opportunity into a genuine public health intervention delivered at scale.

Subject of Research: Documentation and management of at-risk alcohol and illicit drug use among acutely hospitalized internal medicine patients

Article Title: Missed opportunities: the detection and management of at-risk drinking and illicit drug use in acutely hospitalized patients

Article References: Gamboa, D., Kabashi, S., Jørgenrud, B., Lerdal, A., Nordby, G., & Bogstrand, S. T. (2025). Missed opportunities: the detection and management of at-risk drinking and illicit drug use in acutely hospitalized patients. Advances in Drug and Alcohol Research, 5, Article 14149. https://doi.org/10.3389/adar.2025.14149

Image Credits: AI Generated

DOI: 10.3389/adar.2025.14149

Keywords: alcohol screening, illicit drug use, emergency department, electronic health records, AUDIT-4, LC-MS, brief intervention, internal medicine, discharge summaries, ICD-10 coding, substance use assessment, hospital care

The black bean aphid is one of the most destructive pests of common beans in Africa, and its biology makes it a formidable adversary. The insects feed on phloem sap, directly siphoning sugars from the plant, while their sugary excretions of honeydew coat leaf surfaces and promote sooty mold growth that shades out photosynthesis. They also transmit economically significant plant viruses. Left unchecked, aphid infestations can slash yields by more than half, and the pests reproduce with startling speed, developing from first-instar nymph to reproductive adult in as little as 8 to 12 days, often without needing males at all. For the more than 100 million African households that rely on common beans as a critical source of protein, dietary fiber, and micronutrients, that kind of pest pressure is a direct threat to food security.

The Tanzanian team, led by Dominick Stephen Nana with colleagues Paulo John Lyimo and Ramadhani Omari Majubwa, began with a critical quality-control step that much botanical pesticide research skips. Tephrosia vogelii is not a chemically uniform plant. It exists as distinct chemotypes with very different insecticidal potentials, and the most potent of these, chemotype 1, cannot be reliably distinguished from its weaker relatives by appearance alone. The researchers collected young, tender leaves from plants displaying white flowers, a morphological trait previously linked to the elite chemotype, then confirmed their suspicion using liquid chromatography mass spectrometry. The LC-MS analysis revealed a dominant rotenone peak at a retention time of 10.96 minutes with a relative intensity of 95 percent, indicating large abundances of the key bioactive rotenoid, along with five other compounds: deguelin, glycetein, 6,4-dimethoxy-7-hydroxyisoflavone, isoquercitin, and quercetin.

With chemotype 1 identity secured, the team moved to a rigorously designed field experiment in Morogoro, a region of mountainous vegetation and miombo woodland receiving 600 to 1200 millimeters of rain annually. Leaves were crushed and soaked in dichloromethane for 48 hours, and the resulting extract was diluted into eight concentrations ranging from 2 percent to 10.2 percent weight per volume. These were sprayed weekly for four weeks in a randomized complete block design with three replications, alongside cypermethrin 10 percent EC as a positive control and plain water as a negative control. Applications were deliberately timed for early morning or late evening to protect the light-sensitive bioactive compounds from photodegradation, a practical detail that matters enormously for farmers who would use the extract themselves.

The results were striking. Four weeks after the final spray, plots treated with the 10.2 percent extract harbored an average of just 2.33 aphids per plant, compared with 67.0 aphids per plant in the water-only control, a statistically significant difference. Across the trial, the strongest extract achieved an 84 percent reduction in aphid population relative to control, edging remarkably close to the synthetic insecticide’s 93 percent. Leaf damage told a parallel story: the 8 percent extract produced the lowest damage score of 0.7 on a 0-to-4 severity scale at week four, versus 2.3 in untreated plots, where leaves were curled, wrinkled, and blackened with sooty mold. The researchers note that the extracts appear to possess repellent properties as well, which may have contributed to the steady decline in aphid numbers across the sampling period.

Perhaps most compelling for farmers is what happened to the harvest. Treated plots significantly out-yielded controls across every measured parameter, including pod weight, pods per plant, seeds per pod, and hundred-seed weight. The 10.2 percent extract delivered a grain yield of 736.3 kilograms per hectare, a figure statistically indistinguishable from the synthetic insecticide treatment’s 763 kilograms per hectare, while the untreated control limped along at just 401.4 kilograms per hectare. Regression analysis reinforced the causal chain: aphid population density and leaf damage were positively correlated with a coefficient of determination of 0.69, and leaf damage showed a strong negative relationship with yield, with the fitted line explaining roughly 80 percent of the variation. In plain terms, every increment of aphid-driven leaf injury translated directly into lost grain.

The researchers are careful about attribution. Although Tephrosia vogelii is well known as a nitrogen-fixing shrub that enriches soils with biomass, this study applied the extract as a foliar spray rather than a soil amendment, so the yield gains are best explained by reduced pest damage rather than any fertilizing effect. The authors also acknowledge that environmental conditions may have assisted the treatment effects, since heavy rainfall can physically knock aphids off host plants and cooler temperatures slow their reproduction. Still, the consistent superiority of all treated plots over controls across four weekly sampling rounds, combined with the dose-response pattern, points firmly to genuine insecticidal activity rooted in the plant’s chemistry.

That chemistry is the real story here. Rotenone and deguelin are isoflavonoid rotenoids that interfere with cellular respiration in insects, while flavonoids such as quercetin add complementary toxic and repellent effects. Because these compounds work through multiple modes of action, they may also slow the development of resistance, a growing problem with synthetic pesticides that has been documented worldwide. Previous work by some of the same researchers and by collaborators across East Africa has shown that chemotype variation dramatically influences field performance, which is why the LC-MS confirmation step in this study carries such weight. Farmers who unknowingly plant or harvest a weak chemotype could see poor results and abandon botanical pest control altogether, a barrier the authors hope transparent identification methods will overcome.

The economic logic is equally persuasive. Tephrosia vogelii grows readily across the region, can be processed with simple techniques suitable for small-scale farmers, and requires no purchase of imported chemicals. In remote areas where agriculture is both the primary source of revenue and the backbone of food security, the affordability gap for synthetic pesticides is often the deciding factor, and a locally grown alternative that performs comparably to cypermethrin could reshape pest management practice. The authors emphasize that the extracts fit naturally into integrated pest management frameworks and could become the basis for developing and commercializing botanical pesticide products in Tanzania and beyond.

Cautions remain before widescale adoption. The team recommends larger trials spanning multiple locations and seasons, work on formulation stability, assessment of phytotoxicity and effects on non-target organisms, persistence studies, economic analysis, and optimization of application rates. They also call for further investigation of reliable field indicators for chemotype 1 and for long-term ecological monitoring of the extracts. But the central conclusion stands on solid data: chemotype 1 leaf extracts of Tephrosia vogelii suppressed black bean aphids, reduced leaf damage, and lifted common bean yields to near the level of a leading synthetic insecticide, using nothing more than a plant that farmers can grow themselves. As pressure mounts to reduce the human and environmental costs of chemical pest control, this old fish-poison plant may prove to be one of Africa’s most valuable new crop protection tools.

Subject of Research: Botanical pest control of the black bean aphid on common beans using Tephrosia vogelii leaf extracts

Article Title: Field efficacy of Tephrosia vogelii leaf extracts against Aphis fabae Scopoli (Hemiptera: aphididae) on common bean (Phaseolus vulgaris)

Article References: Nana, D. S., Lyimo, P. J., & Majubwa, R. O. (2026). Field efficacy of Tephrosia vogelii leaf extracts against Aphis fabae Scopoli (Hemiptera: aphididae) on common bean (Phaseolus vulgaris). Frontiers in Agronomy, 8, Article 1900866. https://doi.org/10.3389/fagro.2026.1900866

Image Credits: AI Generated

DOI: 10.3389/fagro.2026.1900866

Keywords: Tephrosia vogelii, Aphis fabae, common bean, botanical pesticide, rotenone, chemotype 1, LC-MS, integrated pest management, Tanzania, smallholder farmers, food security, grain yield

The research team, led by Abdurakhmonova Mashkhura Javdatovna of Andijan State Pedagogical Institute in Uzbekistan together with colleagues at several Uzbek institutions and Muhammad Waheed of the University of Okara in Pakistan, designed the experiment around a deceptively simple question: where does the herbicide go once it enters a pregnant body, and what does it do there? To answer it, pregnant Wistar rats received a single oral dose of haloxyfop-R-methyl at one-tenth of the dose lethal to half of exposed animals, a sublethal level intended to model realistic environmental exposure rather than acute poisoning. Crucially, the timing of that dose was varied across three groups, with animals dosed on gestational day 3, gestational day 13, or gestational day 17, spanning the earliest stages of embryonic development through late organogenesis.

On gestational days 20 and 21, near the end of the roughly three-week rat pregnancy, the researchers collected liver, lung, spleen, and brain tissue from both mothers and fetuses and quantified herbicide residues using liquid chromatography coupled with tandem mass spectrometry, the gold-standard analytical technique for trace contaminant detection. The method’s performance was rigorous: calibration curves showed strong linearity, with slopes of 93,384.20 and 97,181.37 and uncentered R-squared values of 0.99993 and 0.99978, meaning the instrument’s signal tracked concentration almost perfectly across the measured range. Control animals showed no detectable herbicide, confirming that the signal in treated animals came from the experimental exposure rather than background contamination.

The residue data revealed a striking pattern. Haloxyfop-R-methyl was present in every maternal and fetal tissue examined, demonstrating that the compound crosses the placenta efficiently and distributes widely through fetal circulation. Concentrations differed among the three exposure-timing groups, with the highest levels appearing in animals dosed latest in pregnancy. In the gestational day 17 group, maternal liver reached 0.619 plus or minus 0.050 micrograms per gram and maternal lung reached 0.529 plus or minus 0.041 micrograms per gram, the highest maternal values recorded. Fetal tissues followed the same trend, with fetal liver peaking at 0.419 plus or minus 0.035 micrograms per gram and fetal lung at 0.405 plus or minus 0.020 micrograms per gram in that same late-exposure group.

Perhaps the most consequential metric was the fetal-to-maternal residue ratio, which expresses how much chemical accumulates in fetal tissue relative to the corresponding maternal tissue. These ratios were highest in several organs in the gestational day 17 group, particularly the lung, liver, and brain. A ratio approaching or exceeding parity means the fetus is not merely passively receiving trace amounts but is accumulating the compound at concentrations comparable to its mother’s, whose liver and kidneys would normally be expected to handle the bulk of detoxification. The elevated brain ratios are especially noteworthy because the developing nervous system is uniquely vulnerable during organogenesis, and the blood-brain barrier that protects the adult brain is still immature in fetal life.

Residue burden was only half of the story. In a parallel experiment, the team measured three standard clinical biomarkers of liver injury in maternal plasma: alanine aminotransferase, or ALT; aspartate aminotransferase, or AST; and total bilirubin. These enzymes and pigments are workhorses of clinical hepatology. ALT and AST leak into the bloodstream when hepatocytes, the liver’s metabolic workhorse cells, are damaged or dying, while bilirubin rises when the liver’s capacity to process heme breakdown products is compromised. Across all three exposure windows, haloxyfop-R-methyl exposure elevated all three biomarkers, with the highest values again occurring in the gestational day 17 group at terminal sampling. The pattern indicates genuine hepatic biochemical injury, not merely chemical presence, and it appeared at a dose well below the lethal threshold.

The authors are careful to flag an important limitation of the timing comparison. Because all groups were sampled on the same gestational days, 20 and 21, the interval between dosing and sampling differed across groups. Animals dosed on day 3 had roughly eighteen days for the herbicide to be metabolized and cleared before measurement, while animals dosed on day 17 had only three or four. The observed differences among exposure-timing groups therefore cannot cleanly distinguish whether late gestation is intrinsically more vulnerable, or whether the higher residues simply reflect less time for elimination. This confound does not undermine the central findings, that the herbicide reaches fetal tissues and injures the maternal liver, but it does temper interpretation of the window-specific differences.

The study also tested a potential countermeasure. The researchers co-administered two plant-derived flavonoids, narcissin and sophoroflavonoside, alongside the herbicide and measured whether they could blunt the biochemical damage. Flavonoids are a large family of polyphenolic plant compounds known for antioxidant and anti-inflammatory properties, and prior work by some of the same authors had suggested they might protect liver mitochondria from pesticide-induced dysfunction. In this experiment, both compounds reduced the pesticide-induced elevations in ALT, AST, and bilirubin, but sophoroflavonoside showed greater protective efficacy across most endpoints, with particularly strong effects on bilirubin in the gestational day 3 group and AST in the gestational day 13 group. Standardized effect-size analysis confirmed that the herbicide produced large effects on the biomarkers and that the flavonoid treatments produced measurable, though incomplete, correction.

Why does this matter beyond the laboratory? Haloxyfop belongs to a class of herbicides whose residues are regulated through maximum residue limits set by food safety authorities, including a targeted review of haloxyfop-P limits by the European Food Safety Authority in 2022. Regulatory risk assessment for pesticides has historically focused on adult toxicity and occupational exposure, with developmental exposure windows receiving less granular attention. Studies like this one, which map residue distribution across maternal and fetal organs at specific gestational stages, feed into the tissue residue approach in toxicology, a framework that argues toxicity is better predicted by the amount of chemical actually present in target tissues than by the external dose an animal receives. By pairing residue quantification with clinical biomarkers, the study offers a template for that integrated approach.

Several caveats frame the translation to human health. Rats are not humans, and the pharmacokinetics of haloxyfop-R-methyl, including its ester hydrolysis to the active acid and its species-dependent induction of peroxisome proliferation documented in earlier work, differ across mammals. The single-dose design, while elegant for isolating timing effects, does not capture the repeated low-level exposures that characterize real-world dietary residue intake. And the flavonoid protection, while encouraging, was partial rather than complete, and the doses and mechanisms in rats cannot be directly prescribed as a human intervention. What the study does establish firmly is that a sublethal gestational dose of a common herbicide distributes into fetal organs, produces measurable maternal liver injury, and that timing of exposure shapes the residue profile. For a chemical applied to food crops worldwide, that combination of placental transfer and hepatic injury at one-tenth of the lethal dose is a data point that regulators, farmers, and expectant parents alike will want to watch closely as follow-up studies attempt to disentangle gestational-stage vulnerability from simple clearance kinetics.

Subject of Research: Gestational exposure to the herbicide haloxyfop-R-methyl and its maternal and fetal residue distribution and hepatic toxicity in Wistar rats

Article Title: Gestational exposure to haloxyfop-R-methyl drives maternal and embryonic residue burden and hepatic biochemical injury in Wistar rats

Article References: Javdatovna, A. M., Parida, M., Komiljonovich, P. M., Abdullayevna, S. G., Abbasovna, A. R., & Waheed, M. (2026). Gestational exposure to haloxyfop-R-methyl drives maternal and embryonic residue burden and hepatic biochemical injury in Wistar rats. Environmental Science and Pollution Research. https://doi.org/10.1007/s11356-026-38308-4

Image Credits: AI Generated

DOI: 10.1007/s11356-026-38308-4

Keywords: haloxyfop-R-methyl, herbicide, pregnancy, placental transfer, pesticide residues, hepatotoxicity, Wistar rats, LC-MS, flavonoids, narcissin, sophoroflavonoside, developmental toxicology

Wild mountain ginseng, Panax ginseng Meyer, occupies a near-mythical status across Korea, China, and Japan, where it has been harvested for centuries as a medicinal herb and health food. Its value stems from ginsenosides, a family of triterpene saponins that constitute the plant’s primary pharmacological constituents. These compounds are conventionally divided into three structural groups: the protopanaxadiol type, which includes well-studied molecules such as Rb1, Rb2, Rb3, Rd, Rg3, and Rh2; the protopanaxatriol type, encompassing Re, Rf, Rg1, Rg2, and Rh1; and the oleanolic acid type, represented by Ro and related saponins. Decades of research have attributed a remarkable spectrum of biological activities to ginsenosides, including immune enhancement, antioxidant and antibacterial effects, antidiabetic and anti-inflammatory actions, anti-aging properties, and cardioprotective and neuroprotective benefits.

The problem, of course, is supply. A wild mountain ginseng root of this age is an extraordinarily rare resource, and demand for authentic, high-quality material far exceeds what nature can provide. The research team’s strategy was to sidestep the bottleneck entirely by generating adventitious roots, roots that arise from somatic tissue rather than from seed germination, from the 150-year-old specimen, designated 150y-Mg. These cultured roots were then scaled up in 1000-liter industrial bioreactors, where they grew in Murashige and Skoog medium supplemented with 5 percent sucrose by weight and 5 milligrams per liter of indole-3-butyric acid, a synthetic auxin that promotes root growth and ginsenoside accumulation.

The central question was whether the cultured roots could genuinely be considered the same plant. To answer it, the researchers turned to SNP genotyping, a technique that reads single-nucleotide variations scattered across the genome and produces a molecular fingerprint unique to each individual. Using a panel of 192 SNP markers, they compared the original mountain ginseng with two independently analyzed adventitious root samples. The result was unambiguous: 100 percent genotype concordance across the entire panel. Of the 192 loci, 184 were homozygous, meaning both copies of the gene carried the same variant, five were heterozygous, and three produced null calls that could not be scored. Calculated across the 189 callable non-null loci, the genetic fixation rate stood at 97.4 percent, a figure that reflects the high homozygosity typical of a long-lived, likely self-purging lineage rather than any discrepancy between the parent plant and its cultured offspring.

With genetic identity confirmed, the team shifted to the metabolome, the complete inventory of small molecules that defines what a plant actually produces. Liquid chromatography coupled with mass spectrometry, or LC–MS, revealed clear chemical differences among the analyzed materials. Within the sample set examined, malonyl ginsenoside Rb2/Rb3 was detected in the original 150-year-old mountain ginseng but not in cultivated Panax ginseng, whereas ginsenosides XVII and F2 appeared in the bioreactor-grown adventitious roots but were absent from cultivated ginseng under the same analytical conditions. The authors are careful to frame these observations as comparison-specific metabolite features rather than validated authentication markers, a distinction that matters for any future attempt to certify the origin of ginseng products in the marketplace.

That caution is scientifically warranted. A single comparison between one wild specimen and one cultivated reference cannot establish whether a particular metabolite is truly characteristic of age, habitat, or lineage. Environmental conditions, developmental stage, and analytical parameters can all shift the metabolic profile of ginseng tissue. What the LC–MS data do provide is a shortlist of candidate compounds, malonyl ginsenoside Rb2/Rb3, ginsenoside XVII, and ginsenoside F2, that now deserve systematic validation across broader and independent ginseng cohorts before they could ever serve as reliable markers of wild mountain provenance.

Complementing the LC–MS work, high-performance liquid chromatography, or HPLC, quantified the ginsenoside content of the adventitious roots and revealed distinct quantitative patterns that set them apart from conventional material. The relative proportions of individual saponins matter enormously for pharmacological activity, since different ginsenosides act on different molecular targets in the human body. A culture line that skews toward particular saponin classes could, with further optimization, become a standardized source of specific bioactive molecules, something that wild-harvested roots, with their inherent variability, can never guarantee.

The biomedical potential of the bioreactor-grown roots was explored through preliminary in vitro assays. These experiments provided early evidence of two activities of considerable commercial and clinical interest: anti-inflammatory effects and the ability to stimulate the proliferation of dermal papilla cells, the specialized fibroblasts at the base of hair follicles that regulate hair growth. The dermal papilla finding in particular hints at possible applications in cosmetics and hair-loss research, an area where ginseng-derived compounds have long attracted attention. The authors emphasize, however, that these are preliminary results, and the path from a cell-culture assay to a validated therapeutic or cosmetic ingredient involves extensive further testing.

What makes this study notable is not any single result but the complete pipeline it demonstrates. A rare, irreplaceable botanical resource was captured genetically, propagated indefinitely in sterile culture, scaled to industrial volumes, verified as a true genetic match, and profiled chemically and functionally, all without the plant ever leaving the laboratory. The 1000-liter bioreactor scale is the crucial detail here: it transforms what would otherwise be a botanical curiosity into a feasible production platform. Adventitious root culture of ginseng has been explored before, but anchoring the technology to a documented 150-year-old wild genotype, with SNP-level traceability, raises the standard for authenticity in an industry plagued by adulteration and mislabeling.

The researchers are candid about the limits of the current work. The metabolite features they observed are candidates, not conclusions, and the in vitro activities require confirmation in more rigorous models. Yet the foundation they have laid, complete genetic concordance, a reproducible culture system, and a defined chemical baseline, gives the field exactly what it needs to move forward: a stable reference material against which future wild and cultivated ginseng samples can be compared. If subsequent studies validate the candidate markers across independent cohorts, the combination of SNP fingerprinting and LC–MS profiling could become a powerful authentication toolkit. And if the anti-inflammatory and dermal papilla activities hold up, the roots of a plant that took 150 years to grow in the mountains may one day be produced by the ton, its ancient chemistry preserved in stainless steel tanks rather than in vanishing forest soil.

Subject of Research: Metabolomic profiling and bioreactor production of adventitious roots from a 150-year-old wild mountain ginseng

Article Title: Metabolomic profiling and biomedical potential of adventitious roots derived from a 150-year-old mountain ginseng

Article References: Lee, H.-S., Han, J.-E., Kwon, A.-R., Son, E.-J., Park, H., Kim, M.-O., Kim, Y. J., Lee, K. Y., Yang, T.-J., Murthy, H. N., Paek, K.-Y., & Park, S.-Y. (2026). Metabolomic profiling and biomedical potential of adventitious roots derived from a 150-year-old mountain ginseng. BMC Plant Biology. https://doi.org/10.1186/s12870-026-10136-1

Image Credits: AI Generated

DOI: 10.1186/s12870-026-10136-1

Keywords: Panax ginseng, mountain ginseng, ginsenosides, adventitious roots, metabolomics, LC-MS, SNP genotyping, plant biotechnology, bioreactor, anti-inflammatory, dermal papilla cells, BMC Plant Biology

The problem the researchers set out to solve is well known to anyone who runs liquid chromatography-mass spectrometry, the workhorse technique of metabolomics. Conventional workflows interrogate a biological sample in a largely undifferentiated way, and the instrument systematically favors molecules that ionize easily. Short-chain fatty acids such as acetic acid and butyric acid, for example, are so poorly ionized and so poorly retained on standard chromatography columns that they often go completely undetected, even when present at biologically meaningful concentrations. The result is a biased, incomplete picture of cellular chemistry, with large regions of chemical space effectively invisible.

Chemists have long tried to fix this with derivatization, the practice of chemically modifying metabolites to make them more detectable. By targeting specific functional groups such as carboxyl, carbonyl, amine, and thiol motifs, derivatization can carve the metabolome into submetabolomes, each with improved ionization and characteristic fragmentation behavior. But most existing approaches label only a single metabolite class at a time, and solid-phase enrichment methods typically require bespoke, custom-synthesized resins tailored to each reactivity type. What has been missing is a unified, modular architecture that can handle many functional groups within a single framework.

MREP fills that gap with a two-step design. In the encoding step, four rationally designed alkyne-tagged probes selectively derivatize their targets: but-3-ynylamine (BYA) labels carboxyl-containing metabolites via carbodiimide-activated acylation, 2,5-dioxopyrrolidin-1-yl 4-ethynylbenzoate (DEB) tags amines, alkyne hydrazide (AHZ) captures carbonyls through nucleophilic addition, and N-propargylmaleimide (NPM) conjugates thiols via Michael addition. Each probe installs a terminal alkyne handle onto the metabolite while preserving its native scaffold. In the capture step, the encoded metabolites are immobilized by copper-catalyzed azide-alkyne cycloaddition, the classic click reaction, onto a single azide-functionalized resin dubbed ACER, for alkyne capture for enrichment and reporter-ion installation.

The ACER resin is where much of the platform’s power resides. After click capture, the resin is washed extensively, physically separating derivatized metabolites from the complex biological matrix, and the bound products are then cleaved under acidic conditions for LC-MS analysis. The resin exhibited a loading capacity of 7.9 nanomoles per milligram, roughly ten times higher than a previously reported chemoselective capture system. Crucially, the same resin works for all four probe types, so researchers no longer need to synthesize a new functionalized support for every metabolite class they wish to interrogate. The embedded valeric amide module also produces a diagnostic reporter ion at m/z 100.0757 in every fragmentation spectrum, a universal signature that flags which features belong to the encoded submetabolomes.

Optimization was a meticulous affair. The team screened amine- and hydrazide-based probes, tested three families of condensation reagents, and varied alkyl linker lengths from three to eight carbons, ultimately selecting the C4 linker for its balance of reactivity and solubility, since the longer C8 variant showed reduced performance toward long-chain fatty acids, likely due to hydrophobic aggregation. Reaction conditions, including probe concentration, temperature, solvent composition, copper catalyst, ligand, and reducing agent, were tuned to work uniformly across all four functional-group channels. Under the final protocol, encoding efficiency exceeded 83.8 percent, capture efficiency exceeded 96.0 percent, and cleavage efficiency exceeded 88.3 percent across a diverse panel of test metabolites.

The sensitivity gains are striking. In their native forms, acetic acid, butyric acid, and succinic acid were undetectable by conventional LC-MS, while phenylalanine, palmitic acid, oleic acid, and eicosapentaenoic acid produced only weak signals. After MREP treatment, all ten carboxyl standards were readily detected in positive ion mode, and across the full panel of carboxyl, amine, carbonyl, and thiol derivatives, limits of detection improved by factors of 20 to 40,000 relative to native analysis. Calibration curves showed excellent linearity over a 1 to 1,000 nanomolar range, and a bifunctional test compound containing both carboxyl and carbonyl groups was quantified accurately through either encoding channel, confirming the platform’s quantitative robustness.

Beyond raw sensitivity, the derivatization imposed a welcome structural order. The triazole-containing derivatives fragmented reproducibly, with the universal reporter ion supplemented by class-specific signatures such as a diagnostic fragment at m/z 237.1352 for carbonyl derivatives and a characteristic neutral loss of 45.0215 daltons for amines. Chromatographic performance also improved, allowing clear separation of positional, epimeric, and hybrid isomers that coeluted in their native forms. To support confident identification, the researchers built an in-house reference library of 115 derivatized standards spanning fatty acids, eicosanoids, bile acids, amino acids, and TCA cycle intermediates, and implemented a local linear regression calibration using nineteen saturated fatty acid calibrants, reducing retention-time deviations to under 5 percent across different gradients, columns, and instruments.

The platform’s real-world credentials were established in a mouse model of alcohol-associated liver disease. Applying MREP to liver tissue and serum from ethanol-fed and pair-fed C57BL/6J mice, the team detected 7,208 putative metabolite features, of which 1,573 in liver and 656 in serum were structurally annotated, with 67 validated against the reference library. Multivariate analysis revealed clear metabolic separation between the dietary groups, and among 191 significantly altered metabolites, the changes tracked known biology: elevated short-chain, monounsaturated, and polyunsaturated fatty acids, increased eicosanoids such as 12,13-DiHOME, raised aromatic amino acids, and decreased pyruvic acid. Notably, several saturated fatty acids and bile acids were detected only under this new framework, and many of the altered metabolites are linked to gut microbial metabolism, consistent with disruption of the gut-liver axis in alcohol-related liver injury.

The authors are candid about limitations: acidic cleavage could in principle affect labile metabolites, though testing showed no significant degradation of the derivatized carboxyl compounds, and densely functionalized molecules may show some cross-reactivity that requires tailored conditions. Even so, the conceptual advance is considerable. By treating chemical encoding not merely as a sensitivity booster but as a structural organizing principle, MREP turns the metabolome’s heterogeneity from an obstacle into a handle. Because the architecture is modular, new probes can extend coverage to additional functional groups through rational design, offering a scalable route toward functionally stratified, high-definition maps of metabolism in health and disease.

Subject of Research: A chemoselective metabolomics platform that stratifies metabolites by functional group reactivity for enhanced LC-MS profiling

Article Title: Chemoselective Metabolomics via a Modular Reactivity‐Encoding Platform

Article References: Tao, X., Zhang, C.-M., Yang, R.-J., Ren, M., Zhong, Z.-L., Wang, K.-H., Hu, R.-X., Liu, J.-Y., Zhou, J.-Y., Li, H.-K., & Wan, J.-B. (2026). Chemoselective Metabolomics via a Modular Reactivity‐Encoding Platform. Advanced Science, 13(56), Article e76599. https://doi.org/10.1002/advs.76599

Image Credits: AI Generated

DOI: 10.1002/advs.76599

Keywords: metabolomics, mass spectrometry, chemical derivatization, click chemistry, LC-MS, submetabolome, fatty acids, bile acids, alcoholic liver disease, solid-phase enrichment, reporter ion, functional group labeling

The researchers, Rahul Narnaware and Pratibha Dhabarde, began by collecting fresh castor plants from the wild regions of the Wardha district and formally authenticating the botanical identity of their specimens. They then prepared two distinct formulations, a methanolic extract of the raw oil and a processed cream, and subjected both to high-resolution chemical profiling using an Agilent 1290 Infinity II UHPLC system coupled to a 6545 Q-TOF mass spectrometer. This analytical setup allowed them to separate and identify the complex mixture of secondary metabolites with a mass accuracy threshold of plus or minus five parts per million, cross-referencing every fragmentation spectrum against the METLIN and PubChem databases.

The profiling effort paid off with the annotation of 24 major metabolites, classified as putatively identified at Level 2 under the Metabolomics Standards Initiative. The chemical diversity was striking: indole alkaloids such as hirsutine and hirsuteine, terpenoid glycosides, cyclic phosphatidic acids, sterols, phenolic compounds, and aliphatic acetogenins all appeared in the chromatograms. Notably, the raw oil was enriched with the indole alkaloids hirsutine and hirsuteine, while the cream formulation showed a higher relative abundance of phenolic compounds, including 2,6-dimethoxyphenol and a long-chain alkylresorcinol known as 5-(12,15-heneicosadienyl)-1,3-benzenediol. This formulation-dependent chemical distribution suggests that the delivery vehicle itself reshapes which bioactive molecules are available at the application site.

With the chemical inventory in hand, the team turned to in vitro screening using two established protein denaturation models. Protein denaturation, the unfolding of a protein’s three-dimensional structure under stress, is considered a key phenomenon in arthritic tissue injury, making its inhibition a common first-line screen for anti-arthritic candidates. The researchers heated egg albumin and bovine serum albumin under controlled conditions and measured how effectively the castor formulations prevented the resulting structural damage, using diclofenac sodium, a widely prescribed NSAID, as the reference standard.

The results were eye-catching. At the highest tested concentration of 6400 micrograms per milliliter, the cream formulation achieved 97.80 percent inhibition of BSA denaturation and 96.20 percent inhibition of egg albumin denaturation, compared with roughly 72 to 75 percent for diclofenac sodium under the same conditions. The differences were statistically significant at p less than 0.001, and the formulations showed measurable, dose-dependent protection even at concentrations as low as 100 micrograms per milliliter. The authors are careful to stress that these are cell-free, non-specific screening assays: they demonstrate a remarkable capacity for structural stabilization under thermal stress, but they do not establish clinical superiority over established NSAIDs or account for pharmacokinetics and systemic inflammatory pathways in living organisms.

To probe the molecular mechanisms behind these observations, the team docked 24 metabolites against three central players in the inflammatory cascade: cyclooxygenase-2, or COX-2, the enzyme responsible for producing pro-inflammatory prostaglandins; interleukin-6, a cytokine that drives systemic inflammation; and tumor necrosis factor-alpha, another master regulator of inflammatory signaling. Using the AutoDock Vina algorithm with a validated protocol confirmed by re-docking the native ligands, the researchers found several compounds with predicted binding affinities rivaling synthetic drugs. Hirsutine topped the list with a binding free energy of minus 9.3 kilocalories per mole in the COX-2 pocket, forming hydrogen bonds with the residues ARG120, TYR355, and SER530. The SER530 interaction is particularly significant because this residue sits at the heart of the cyclooxygenase active site and is central to how established NSAIDs achieve competitive inhibition.

The cytokine targets yielded equally intriguing candidates. Tsangane L 3-glucoside, a terpenoid glycoside, showed a predicted affinity of minus 8.8 kilocalories per mole at the IL-6 receptor interface, making contact with ARG179 and GLU172, while cyclic phosphatidic acids demonstrated structural complementarity at the same interface with a score of minus 8.6 kilocalories per mole. On the TNF-alpha front, the alkylresorcinol 5-(12,15-heneicosadienyl)-1,3-benzenediol achieved minus 8.7 kilocalories per mole, anchored by interactions with TYR59 and LEU120, a binding mode that the authors suggest could potentially stabilize the inactive trimeric conformation of the cytokine.

Static docking snapshots can be misleading, so the team ran 200-nanosecond atomistic molecular dynamics simulations using the GROMACS 2022 package with the CHARMM36 force field, explicitly solvating each protein-ligand complex in water with physiological salt concentrations. All three prioritized complexes, hirsutine with COX-2, tsangane L 3-glucoside with IL-6, and the alkylresorcinol with TNF-alpha, reached structural equilibrium by 170 nanoseconds and remained stable through the end of the production run. Low root-mean-square fluctuation values across active site residues indicated limited local flexibility upon ligand binding, while consistent radii of gyration showed that the proteins did not unfold. Free energy landscape analysis revealed funnel-shaped energy minima, suggesting that the predicted ligand orientations correspond to thermodynamically favorable states with a low probability of spontaneous dissociation within the simulation.

The authors are refreshingly candid about the limits of their work. The metabolite annotations remain putative in the absence of physical isolation and nuclear magnetic resonance confirmation, and the docking and simulation results represent structural hypotheses rather than demonstrated biological activity. No kinetic enzymatic assays, cellular cytokine expression studies, or in vivo pharmacokinetic analyses have yet been performed, and the protein denaturation data cannot be extrapolated to therapeutic efficacy in patients. What the study does deliver is a systematically characterized chemical map and a set of high-probability binding hypotheses that transform castor plant research from empirical observation into a rational starting point for drug discovery.

Those hypotheses are worth taking seriously. The indole scaffold of hirsutine, which structurally mirrors the binding orientation of high-affinity COX-2 inhibitors, could serve as a template for semi-synthetic optimization, while the cyclic phosphatidic acids open an unexplored avenue for cytokine interface modulation. If follow-up studies in mammalian cell lines and animal models of rheumatoid arthritis confirm even a fraction of the predicted activity, the ancient castor plant may yet contribute modern molecular medicine, bridging the gap between ethnobotanical tradition and the demanding standards of contemporary pharmacology.

Subject of Research: Phytochemical and computational analysis of the anti-inflammatory and anti-arthritic potential of Ricinus communis L. oil and cream formulations

Article Title: Metabolic profiling and multitarget in silico docking reveal the anti inflammatory and anti arthritic potential of Ricinus communis L formulations

Article References: Narnaware, R., & Dhabarde, P. (2026). Metabolic profiling and multitarget in silico docking reveal the anti inflammatory and anti arthritic potential of Ricinus communis L formulations. Discover Chemistry, 3(1), Article 519. https://doi.org/10.1007/s44371-026-00979-w

Image Credits: AI Generated

DOI: 10.1007/s44371-026-00979-w

Keywords: Ricinus communis, castor oil, anti-inflammatory, rheumatoid arthritis, COX-2, IL-6, TNF-alpha, molecular docking, molecular dynamics, LC-MS, protein denaturation, natural products